# Senti Biosciences Holdings, Inc.: Form 8-K, filed Jul 15, 2026

- Company: [Senti Biosciences Holdings, Inc.](/companies/snti.md) (CIK 1854270)
- Form: 8-K
- Filed: 2026-07-15
- Accepted by EDGAR: Jul 15, 2026, 07:32 ET
- Period: 2026-07-14
- Accession: 0001628280-26-048248
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1854270/000162828026048248/snti-20260714.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1854270/000162828026048248/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 5.01: Change in control
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1854270/000162828026048248/snti-20260714.htm

Filed Jul 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-048248. Last ingested by Listed: Oct 27, 2026, 16:38 ET. No prices; not investment advice.